DLRC Group
Private Company
Funding information not available
Overview
DLRC Group is a private, revenue-generating services firm formed through the acquisition and expansion of established regulatory consultancies. Founded in 2023 as a holding entity, it consolidates the UK-based DLRC Ltd (founded 2005), Germany's Orphix Consulting GmbH (acquired 2020), and the newly established US office, DLRC Inc. (2023). The group offers a seamless, single-point-of-contact service model, providing expert regulatory strategy and submission support for diagnostics and medical device companies across major global markets. Its value proposition is built on decades of collective experience, multilingual teams, and close relationships with regulatory agencies.
Technology Platform
Intellectual capital and service platform for global regulatory strategy, submissions, and representative services for diagnostics and medical devices.
Opportunities
Risk Factors
Competitive Landscape
Competes with large, full-service CROs (like IQVIA, Parexel) that have regulatory divisions, as well as numerous small-to-midsize specialist regulatory consultancies. Differentiation is based on deep sector focus (diagnostics/devices), personalized service, and integrated global coverage through a single contact.